Cognigen Corporation, a division of Simulations Plus

Cognigen Corporation, a division of Simulations Plus, stands at the forefront of pharmaceutical manufacturing, offering unparalleled strategic clinical pharmacology and pharmacometric consulting services. Located at 1780 Wehrle Drive, Suite 110, Buffalo, NY 14221-7000, US, Cognigen is dedicated to advancing the science and engineering the systems of model-based drug development. With a rich history dating back to its founding in 1992, Cognigen consistently delivers high-quality, comprehensive technical reports that synthesize analysis findings. These reports enable knowledge-based decision-making at critical regulatory and drug development milestones.

Cognigen Corporation provides an array of services, including PK/PD model development, clinical trial simulations, exposure-response evaluations, and related data management services. The company's multidisciplinary scientific teams are adept at data assembly, NONMEM, dose justification, and CTD 272, ensuring reliable and actionable results. Cognigen's commitment to innovation is further exemplified by its PERSPECTIVE Hypertext Data Analysis Mapping software and Internet-based client collaboration strategy. These tools allow integrated project teams to engage in real-time collaborative review of results, enhancing the efficiency and accuracy of drug development processes.

With its expertise in exposure-response analyses, forensic pharmacometrics, systems pharmacology, noncompartmental analysis, and PBPK modeling, Cognigen Corporation is a trusted partner in the pharmaceutical industry. Cognigen Services is now an integral part of Simulations Plus, further solidifying its position as a leader in clinical pharmacology and pharmacometrics. We invite the management team at Cognigen Corporation to create a customized and exclusive company showcase and product listing on our platform to further amplify its presence and reach within the pharmaceutical community.